Evidence map›Paper›PMID 29531172›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Constitutively Bound EGFR-Mediated Tyrosine Phosphorylation of TLR9 Is Required for Its Ability To Signal.

Manoj Veleeparambil, Darshana Poddar, Samar Abdulkhalek, Patricia M Kessler, Michifumi Yamashita, Saurabh Chattopadhyay, Ganes C Sen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. EGF-Receptor-Dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis.Laboratory investigation; a journal of technical methods and pathology · 2023
    Article
  8. Unexpected Need of the Epidermal Growth Factor Receptor Tyrosine Kinase Activity for Signaling by Intracellular Pattern Recognition Receptors of Nucleic Acids.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  9. Development and function of chicken XCR1Frontiers in immunology · 2023
    Article
  10. Review
  11. Survival of HT29 Cancer Cells Is Affected by IGF1R InhibitionPathology oncology research : POR · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ifi204/p204, a new piece in the sepsis puzzle.Annals of translational medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Manoj VeleeparambilDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0003-3545-5251
Darshana PoddarDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Samar AbdulkhalekDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0002-2527-3406
Patricia M KesslerDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Michifumi YamashitaDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0001-6221-8900
Saurabh ChattopadhyayDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0002-2930-1523
Ganes C SenDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195 seng@ccf.org.
Cleveland Clinic Lerner College of Medicine · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
TELOMERASE INACTIVATION BY RNASE L SIGNALS CELL DEATHP01CA062220 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA, STARK, GEORGE ROBERT · 1994 to 2020
$35.6M
ANTIVIRAL ACTIONS OF INTERFERONSR01CA068782 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, GANES C. · 1995 to 2020
$7.6M
Leica TCS SP8 Confocal Microscope for a Core FacilityS10OD019972 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI DRAZBA, JUDY · 2015 to 2015
$544k
NCATS NIH HHS UL1 TR001881NCI NIH HHS P01 CA062220NCI NIH HHS R01 CA068782NIH HHS S10 OD019972
6 · The paper itself

Abstract

Mammalian TLRs recognize microbial infection or cell death-associated danger signals and trigger the appropriate cellular response. These responses determine the strength and the outcome of the host-microbe interaction. TLRs are transmembrane proteins located on the plasma or the endosomal membrane. Their ectodomains recognize specific microbial or endogenous ligands, and the cytoplasmic domains interact with specific proteins to activate intracellular signaling pathways. TLR9, an endosomal TLR, is activated by endocytosed DNA. Activated TLR9 recruits the cytoplasmic adapter MyD88 and other signaling proteins to induce the synthesis of inflammatory cytokines and IFN. Uncontrolled activation of TLR9 leads to the undesired overproduction of inflammatory cytokines and consequent pathogenesis. Therefore, appropriate activation and the regulation of TLR9 signaling are critical. Tyrosine (Tyr) phosphorylation of TLR9 is essential for its activation; however, the role of specific Tyr kinases is not clear. In this article, we report that epidermal growth factor receptor (EGFR), a membrane-bound protein Tyr kinase, is essential for TLR9 signaling. Genetic ablation of EGFR or pharmacological inhibition of its kinase activity attenuates TLR9-mediated induction of genes in myeloid and nonmyeloid cell types. EGFR is constitutively bound to TLR9; upon ligand stimulation, it mediates TLR9 Tyr phosphorylation, which leads to the recruitment of MyD88, activation of the signaling kinases and transcription factors, and gene induction. In mice, TLR9-mediated liver injury and death are blocked by an EGFR inhibitor or deletion of the EGFR gene from myeloid cells, which are the major producers of inflammatory cytokines.

Indexed as

AnimalsErbB ReceptorsHumansMacrophagesMicePhosphorylationSignal TransductionToll-Like Receptor 9TyrosineErbB ReceptorsToll-Like Receptor 9Tyrosine

Identifiers

PMID29531172
PMCPMC5893352
OpenAlexW2794117012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.